BROADWOOD CAPITAL INC Long-Term Concentrated

Location: New York, NY

CIK: 0001278387 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $1.322B (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 38.8%

Value $513M Shares 10,768,431 Est. Cost $14.70 Unrealized +198.1%

MNST MONSTER BEVERAGE CORP NEW 31.3%

Value $414M Shares 8,295,690 Est. Cost $36.99 Unrealized +43.3%

AXON AXON ENTERPRISE INC 16.9%

Value $224M Shares 760,062 Est. Cost $27.50 Unrealized +985.3%

IWM ISHARES TR 8.7%

Value $115M Shares 566,000 Est. Cost $112.69 Unrealized —

LCTX LINEAGE CELL THERAPEUTICS IN 3.1%

Value $41.55M Shares 41,666,255 Est. Cost $1.06 Unrealized +4.3%

IMDX ONCOCYTE CORP 1.1%

Value $14.54M Shares 4,929,066 Est. Cost $3.24 Unrealized -15.3%

SER SERINA THERAPEUTICS INC 0.1%

Value $816K Shares 85,219 Est. Cost $14.17 Unrealized -30.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	10,768,431	$513M	38.8%	$14.70	+198.1%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	8,295,690	$414M	31.3%	$36.99	+43.3%	COM	61174X109
AXON	AXON ENTERPRISE INC	760,062	$224M	16.9%	$27.50	+985.3%	COM	05464C101
IWM	ISHARES TR	566,000	$115M	8.7%	$112.69	—	RUSSELL 2000 ETF	464287655
LCTX	LINEAGE CELL THERAPEUTICS IN	41,666,255	$41.55M	3.1%	$1.06	+4.3%	COM	53566P109
IMDX	ONCOCYTE CORP	4,929,066	$14.54M	1.1%	$3.24	-15.3%	COM NEW	68235C206
SER	SERINA THERAPEUTICS INC	85,219	$816K	0.1%	$14.17	-30.6%	COM SHS	81751A108